title: Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
authors.forename: Casey B
authors.initials: CB
authors.lastname: Cottrill
authors.forename: Steven C
authors.initials: SC
authors.lastname: Matson
mesh_terms: D000286:Administration, Sublingual; D000293:Adolescent; D000067697:Adolescent Health; D000701:Analgesics, Opioid / Q000378:metabolism; D016739:Behavior, Addictive / Q000628:therapy; D002047:Buprenorphine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000069479:Buprenorphine, Naloxone Drug Combination / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D062787:Drug Overdose / Q000517:prevention & control; D006801:Humans; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D058850:Opiate Substitution Treatment / Q000379:methods*; D009293:Opioid-Related Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000628:therapy; D010348:Patient Care Team; D010349:Patient Compliance; D017410:Practice Guidelines as Topic; D017450:Receptors, Opioid, mu / Q000378:metabolism; D015813:Substance Abuse Detection
chemical_list: D000701:Analgesics, Opioid; D000069479:Buprenorphine, Naloxone Drug Combination; D009292:Narcotic Antagonists; D017450:Receptors, Opioid, mu; D002047:Buprenorphine